PUBLICATIONS

Advancing Lung Cancer Care: New Treatment Insights Highlighted During Awareness Month As Lung Cancer Awareness Month brings attention to the disease, the impact of lung cancer worldwide remains grave, with around 1.8 million lives lost each year. Recent findings in cancer research bring encouraging news: a new combination therapy of amivantamab and lazertinib offers a substantial improvement for those with advanced non-small cell lung cancer (NSCLC). Read more

World Diabetes Day Focus: The Role of GLP-1 Agonists and SGLT2 Inhibitors in Diabetes Treatment Key takeaways:  GLP-1 Agonists and SGLT2 Inhibitors are two effective medication classes for managing Type 2 diabetes, each offering unique benefits.  GLP-1 Agonists (e.g., Ozempic) provide significant blood sugar control and weight loss, ideal for patients prioritizing weight management.  SGLT2 Inhibitors (e.g., Jardiance) offer strong heart and kidney protection, often recommended for patients with heart Read more

Clinical Research Focus. 34th Edition Navigating the EU Clinical Trials Regulation: Insights and Challenges for Sponsors         The EU Clinical Trials Regulation is reshaping the clinical trial landscape, offering a more streamlined and transparent process while introducing new challenges for sponsors. In this interview, Cromos Pharma’s EU Regulatory Lead, Monika David, discusses how the CTR harmonizes trial processes, the Read more

Changing Defibrillator Pad Placement Increases Survival by 164% A recent trial has revealed that placing defibrillator pads in an anterior-posterior (AP) configuration—on the chest and back—can increase the odds of surviving an out-of-hospital cardiac arrest (OHCA) by more than two-and-a-half times compared to the traditional anterior-lateral (AL) positioning, where both pads are placed on the chest. These findings offer a significant advancement in Read more